My Portfolio
+
LINK YOUR PORTFOLIO

Armata Pharmaceuticals Inc ARMP:NYSE American

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 4:00 PM EDT
7.70quote price arrow down-0.22 (-2.78%)
Volume
31,056
52 week range
1.74 - 16.34
Loading...
  • Open7.90
  • Day High7.93
  • Day Low7.49
  • Prev Close7.92
  • 52 Week High16.34
  • 52 Week High Date10/22/25
  • 52 Week Low1.74
  • 52 Week Low Date06/16/25

Latest On Armata Pharmaceuticals Inc

 

Key Stats

  • Market Cap282.673M
  • Shares Out36.71M
  • 10 Day Average Volume0.07M
  • Dividend-
  • Dividend Yield-
  • Beta1.24

Latest On Armata Pharmaceuticals Inc

 

KEY STATS

  • Open7.90
  • Day High7.93
  • Day Low7.49
  • Prev Close7.92
  • 52 Week High16.34
  • 52 Week High Date10/22/25
  • 52 Week Low1.74
  • 52 Week Low Date06/16/25
  • Market Cap282.673M
  • Shares Out36.71M
  • 10 Day Average Volume0.07M
  • Dividend-
  • Dividend Yield-
  • Beta1.24

RATIOS/PROFITABILITY

  • EPS (TTM)-7.76
  • P/E (TTM)-0.99
  • Fwd P/E (NTM)-8.28
  • EBITDA (TTM)-30.132M
  • ROE (TTM)-3,439.35%
  • Revenue (TTM)5.202M
  • Gross Margin (TTM)-
  • Net Margin (TTM)-5,432.80%
  • Debt To Equity (MRQ)-110.05%

EVENTS

  • Earnings Date08/10/2026(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Profile

MORE
Armata Pharmaceuticals, Inc. is a clinical-stage biotechnology company focused on the development of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using its bacteriophage-based technology. It is developing and advancing a broad pipeline of natural and synthetic phage candidates, including clinical candidates for Pseudomonas aeruginosa, Staphylococcus aureus, and other pathogens. It is...
Robin Kramer
Independent Chairman of the Board
Deborah Birx M.D.
Chief Executive Officer, Director
David House
Principal Financial Officer, Senior Vice President - Finance
Address
5005 Mcconnell Ave
Los Angeles, CA
90066
United States